Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury
- 1 February 2003
- journal article
- review article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 75 (2) , S649-S655
- https://doi.org/10.1016/s0003-4975(02)04691-x
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Inhibition of the Tissue Factor-Thrombin Pathway Limits Infarct Size after Myocardial Ischemia-Reperfusion Injury by Reducing InflammationThe American Journal of Pathology, 2000
- Protease-activated receptor 3 is a second thrombin receptor in humansNature, 1997
- Endothelial cell injury in cardiovascular surgery: The procoagulant responseThe Annals of Thoracic Surgery, 1996
- Regulation of the Tissue Factor Promoter in Endothelial CellsJournal of Biological Chemistry, 1995
- Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.Journal of Clinical Investigation, 1994
- Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.Journal of Clinical Investigation, 1993
- Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion.Journal of Clinical Investigation, 1991
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991
- Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascadeCell, 1987
- Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs.Journal of Clinical Investigation, 1975